Psychological characteristics of cancer patients who use complementary therapies

Psycho-oncology
Robin DavidsonRoger Woodward

Abstract

There has been considerable research on the prevalence and demographic profile of cancer patients who opt to supplement conventional therapies with the use of complementary therapy. There is rather less information on the personality and adjustment variables associated with the decision to use complementary therapy. The aim of the present study is to investigate the relationship between the use of complementary therapies by cancer patients and their mental adjustment to cancer, recovery locus of control, life orientation and psychopathology. Two groups were drawn from a regional centre which provides both conventional and complementary cancer treatments. Participants in Group 1 (n = 61) opted for complementary therapies in addition to conventional treatments for cancer, while participants in Group 2 (n = 56), chose conventional treatment only. All participants completed the Mental Adjustment to Cancer Scale (MAC), the Recovery Locus of Control Scale (RLOC), the life orientation test (LOT), and the Hospital Anxiety and Depression Scale (HADS). Information regarding demographic details and patients' motivation for the use of complementary therapy was also collected. Those people who chose complementary therapy demonstrated a ment...Continue Reading

References

Feb 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·S MooreyJ Bliss
Feb 1, 1989·The British Journal of Clinical Psychology·C Partridge, M Johnston
Aug 1, 1986·Journal of Personality and Social Psychology·G MarksA Levine
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Nov 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·J Harrison, P Maguire
Aug 1, 1993·Journal of Personality and Social Psychology·C S CarverK C Clark
Feb 1, 1996·The British Journal of Clinical Psychology·C Vincent, A Furnham
Sep 1, 1996·Scientific American·J J Aulas
Nov 18, 1996·The Medical Journal of Australia·R M Lowenthal
Jun 1, 1996·European Journal of Cancer Care·K Redmond
May 30, 1998·JAMA : the Journal of the American Medical Association·J A Astin
May 18, 1999·Archives of Otolaryngology--head & Neck Surgery·P D WarrickP Gullane
Jun 3, 1999·Cancer Practice·G K WyattK C Beckrow
Jun 3, 1999·The New England Journal of Medicine·H J BursteinJ C Weeks
Oct 8, 2003·Patient Education and Counseling·M J VerhoefM O'Beirne
Oct 8, 2003·Patient Education and Counseling·T Truant, J L Bottorff
Oct 17, 2003·Patient Education and Counseling·P RitvoB F Shaw

❮ Previous
Next ❯

Citations

Jun 11, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Koji YoshimuraYoichi Arai
Nov 17, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Andrea SainiLuca Ostacoli
Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Jun J MaoFrances K Barg
Mar 30, 2010·Complementary Therapies in Clinical Practice·Mary Mitchell
May 21, 2005·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Dai RobertsAnn-Louise Caress
Sep 8, 2010·Japanese Journal of Clinical Oncology·Markus ZengerAndreas Hinz
Nov 23, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Stephanie J SohlAnn S Hamilton
Aug 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A TrimbornUNKNOWN Working Group Prevention and Integrative Oncology of the German Cancer Society
Feb 21, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rashmi S BismarkMartin C Mahoney
Sep 2, 2014·BMC Complementary and Alternative Medicine·Lena Schützler, Claudia M Witt
Aug 7, 2013·Journal of Pain and Symptom Management·Andrea BonacchiGuido Miccinesi
Nov 3, 2010·Explore : the Journal of Science and Healing·Kristina L McFaddenTiffany A Ito
Jul 12, 2011·Complementary Therapies in Clinical Practice·Maria ArmanAnna Kullberg
Apr 4, 2006·Hematology/oncology Clinics of North America·Lawrence B Berk
Oct 9, 2008·Scandinavian Journal of Caring Sciences·Maria ArmanKathrin Wode
Sep 30, 2010·Psycho-oncology·Mateya TrinkausCamilla Zimmermann
Jun 5, 2013·European Journal of Cancer Care·G SkaczkowskiV Knott
Nov 26, 2015·Palliative & Supportive Care·Miyuki Nagashima-NishimakiMinoru Takebayashi
May 20, 2014·Asia-Pacific Journal of Clinical Oncology·Grace V EdwardsThomas P Shakespeare
Dec 30, 2014·Complementary Therapies in Clinical Practice·M MatthewsK M A Rogers
Oct 29, 2008·Qualitative Health Research·Alex Broom, Philip Tovey
Apr 18, 2015·Qualitative Health Research·Vandhana RamaduraiSrividya Ramasubramanian
Jan 20, 2007·Cancer Nursing·Sebahat GözümMustafa Büyükavci
Apr 10, 2018·Integrative Cancer Therapies·Maryam QureshiLinda E Carlson
Apr 4, 2021·Journal of Cancer Research and Clinical Oncology·Sabine Andrea DufterBijan Zomorodbakhsch
Jun 30, 2021·BMC Women's Health·Daniela PaepkeChristine Brambs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.